Enabling innovation through scientific partnership and biobanking excellence
We recognize that every organization—whether pharma, research, government, or healthcare providers—has unique goals. Our services are designed to meet each partner where they are, helping turn biospecimens, data, and insights into meaningful outcomes.
Pharmaceutical companies face constant pressure to deliver therapies faster, safer, and more cost-effectively. We provide high-quality biospecimens, data integration, and translational support that shorten timelines and reduce risk. We help assemble targeted disease cohorts across multiple geographies, based on recall by genotype/phenotype data, to accelerate clinical trials by reducing timelines.
We empower academic centers with curated cohorts, molecular diagnostic services, and advanced omics analytics. Partners accelerated their research outcomes leveraging our digital pathology expertise to validate tissue biomarkers for range of diseases. Our integrated approach helps researchers publish faster, secure funding, and compete globally.
We help governments establish resilient national biobanks, ensuring long-term disease surveillance and population health planning. We endeavour to support national disease registries by integrating biobanking infrastructure and regulatory oversigh.
Every clinical sample has the potential to improve patient care. We support hospitals and healthcare networks by preserving high quality diverse biospecimens, enabling participation in research collaborations, and creating new value streams.
Abu Dhabi Biobank sets a new global benchmark in sample quality, regulatory compliance, and scientific excellence.
Operating under ISO and other international guidelines
Molecular scientists, bioinformaticians, and regulatory specialists with decades of experience in biobanking and translational research.
Spanning collection, processing, storage, data integration, analytics, and clinical trial support.
De-identified, diverse, unique under-represented databases linked to clinical and demographic data.
Trusted by pharma, academia, and public health systems.
Based in Abu Dhabi and 8-hour flight away from 75% of the world’s population to provide global cold-chain logistics and access to diverse patient populations.
